Acelrx pharmaceuticals inc (ACRX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Revenue:
Revenue

2,410

2,289

2,427

2,196

2,073

2,151

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration agreement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,996

17,297

16,469

14,857

14,756

5,718

5,303

5,217

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Contract and other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,656

7,417

5,638

4,406

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research grant

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,570

3,188

3,005

2,394

1,127

1,001

0

-

0

0

-

-

-

Revenue

-

-

-

-

-

-

-

-

-

-

13,690

15,569

17,441

17,357

12,652

24,714

22,107

19,263

22,358

7,001

0

-

0

0

-

29,502

0

0

0

-

-

-

-

-

-

-

-

-

-

Operating costs and expenses:
Cost of goods sold

7,087

6,806

6,426

5,153

4,092

3,976

3,700

4,854

7,648

10,659

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,924

8,345

5,369

1,770

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

4,696

4,661

6,302

8,886

11,001

13,137

14,109

14,380

16,003

19,409

22,067

22,771

24,150

21,402

18,547

19,323

20,353

22,488

26,290

26,141

26,115

24,520

21,557

22,861

21,685

26,292

29,769

30,169

29,455

24,908

21,815

18,814

16,449

13,624

10,437

8,523

0

0

0

Selling, general and administrative

48,362

45,027

39,889

34,141

26,756

20,765

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating costs and expenses

60,145

56,494

52,617

48,180

41,849

37,878

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

-

-

-

-

-

-

-

-

-

-

16,778

16,517

15,958

15,597

15,536

14,321

13,459

14,203

14,910

16,630

18,942

18,346

16,928

14,588

11,611

9,877

8,480

7,580

7,286

7,199

7,005

7,461

7,315

6,800

6,175

5,585

0

0

0

Restructuring costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

756

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating costs and expenses

-

-

-

-

-

-

-

-

-

-

51,703

52,696

52,949

49,314

45,007

41,989

39,183

39,217

41,956

43,527

45,811

42,866

38,485

37,449

33,296

36,169

38,249

37,749

36,741

32,107

28,820

26,275

23,764

20,424

16,612

14,108

0

0

0

Loss from operations

-57,735

-54,205

-50,190

-45,984

-39,776

-35,727

-32,557

-32,090

-34,878

-38,682

-38,013

-37,127

-35,508

-31,957

-32,355

-17,275

-17,076

-19,954

-17,487

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other expense:
Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Interest expense

3,014

2,535

2,163

1,864

1,950

2,217

2,478

2,868

3,185

3,316

3,297

3,080

2,864

2,770

2,750

2,761

2,851

2,977

3,117

3,220

2,973

2,639

2,131

1,663

1,536

1,518

1,723

1,948

2,143

2,283

2,182

1,986

1,544

2,309

2,089

1,926

0

0

0

Interest income and other (expense) income, net

1,474

2,166

2,223

1,890

1,629

1,138

1,368

591

792

510

403

508

353

918

105

196

-41

1,720

8,471

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest income (expense) on liability related to future sale of royalties

-3,787

-1,337

1,242

5,141

9,132

10,341

11,510

11,365

10,979

10,721

10,396

10,029

9,744

9,382

9,067

6,948

4,624

2,428

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expense

2,247

968

-1,182

-5,115

-9,453

-11,420

-12,620

-13,642

-13,372

-13,527

-13,290

-12,601

-12,255

-11,234

-11,712

-9,513

-7,516

-3,685

-3,704

3,300

6,288

4,296

3,918

-4,150

-15,638

-16,759

-15,315

-12,804

-3,181

-1,367

453

291

-47

1,560

916

881

0

0

0

Net loss before income taxes

-

-

0

0

-

-

0

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

0

0

-

-34,679

-34,561

-33,736

-29,713

-27,477

-24,690

-22,363

-19,352

-16,164

-14,068

0

0

0

Net loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-24,592

-

-12,410

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision (benefit) for income taxes

-

-

-

0

-

-

-

0

-

-

0

0

-

-34

-46

762

762

760

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-55,491

-53,240

-51,375

-51,102

-49,231

-47,149

-44,476

-45,031

-47,549

-51,508

-51,305

-49,694

-47,727

-43,157

-44,021

-27,550

-25,354

-24,399

-27,671

-32,069

-33,748

-33,353

-1,766

-13,423

-20,295

-23,426

-51,717

-49,313

-39,060

-33,363

-29,214

-26,393

-23,962

-20,101

-17,329

-15,105

0

0

0

Other comprehensive loss:
Unrealized losses on available for sale securities

-

-

-

-

-

-

-

-

-

-3

-1

-6

-6

4

-1

5

4

3

7

4

0

-

0

0

-

-

3

2

1

1

6

0

0

-

0

-

-

-

-

Comprehensive loss

-55,491

-53,240

-51,375

-51,102

-49,231

-47,149

-44,476

-45,031

-47,547

-51,511

-51,306

-49,700

-47,733

-43,153

-44,022

-27,545

-25,350

-24,396

-27,669

-32,067

-33,749

-33,358

-1,770

-13,423

-20,293

-23,426

-51,714

-49,311

-39,059

-33,362

-29,219

-26,396

-23,964

-20,101

0

0

0

-

-

Net loss per share of common stock, basic (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.24

-0.24

-0.23

0.11

-0.20

-0.23

-0.33

0.02

-0.24

-0.22

-

-0.26

-0.47

-

-

-

-

-

-

-

-

-

-

-

Net loss per share of common stock, diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.24

-0.25

-0.24

0.11

-0.20

-0.27

-0.26

-0.13

-0.30

-0.22

-

-0.26

-0.47

-

-

-

-

-

-

-

-

-

-

-

Shares used in computing net loss per share of common stock, basic (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45,312

45,286

44,577

44,406

44,343

43,873

43,715

43,469

43,333

43,190

-

41,462

37,262

-

-

-

-

-

-

-

-

-

-

-

Shares used in computing net loss per share of common stock, diluted see Note 14 (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45,312

45,296

44,054

45,049

44,343

44,426

45,525

44,263

44,310

43,190

-

41,462

37,262

-

-

-

-

-

-

-

-

-

-

-

Net loss per share of common stock, basic and diluted (in dollars per share)

-0.20

-0.18

-0.16

-0.16

-0.17

-0.17

-0.21

-0.20

-0.23

-0.19

-0.28

-0.29

-0.34

-

-0.25

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.34

-

-0.38

-0.35

-0.36

-0.31

-0.30

-0.25

-0.30

-5.38

-5.41

Shares used in computing net loss per share of common stock, basic and diluted – See Note 12 (in shares)

80,057

79,584

79,461

78,902

78,788

70,857

60,004

51,841

50,930

50,440

46,365

45,379

45,348

-

45,319

-

-

-

-

-

-

-

-

-

-

-

-

-

37,133

-

22,632

20,627

19,607

19,803

19,458

19,374

10,742

668

653

Product [Member]
Revenue

1,978

1,830

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract and Other Collaboration [Member]
Revenue

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration Agreement Revenue [Member]
Revenue

-

-

0

0

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract and Other [Member]
Revenue

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-